Brian McCann day-to-day after tests come back negative on foot

5 Comments

Brian McCann was forced to make an early exit from Wednesday’s game against the Mariners due to right foot soreness, but the Yankees got some good news today.

According to Andrew Marchand of ESPN New York, McCann is considered day-to-day after an MRI and a CT scan on his foot both came back negative. The 31-year-old backstop originally hurt his foot on May 24 and has been playing through pain since, but apparently it’s nothing serious.

After a strong finish to May, McCann is batting .248/.315/.452 with eight home runs and 33 RBI over 45 games this season. Of course, his value goes beyond what he does at the plate. According to Eno Sarris of FanGraphs, McCann has been the second-best defensive catcher in the game if you include his blocking, framing, and game-calling. Relying on John Ryan Murphy would be a pretty big downgrade, so the Yankees will have to hope that the foot issue doesn’t linger.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.